Stocx Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Aditya Sharma    

Mumbai, India

I am a MBA students and simultaneously reading on capital market to get some knowledge on fundamental research where I more focus on business model, opportunity size of the industry and their related parameters who help me out to find out great businesses for the investment. Nevertheless, I always look forward to learn about grow further into the same.

Read More..
Contributor since: 2022








Comments: 0 | Likes: 1 | Current Price: ₹ 993.6

Godrej Consumer Products Ltd. (GCPL)

Q4FY23 and FY23 Result Analysis

Q4FY23 Performance Highlight

  • Consolidated sales grew by 10% YoY to Rs 32 bn.
  • Domestic business grew by 11.5% YoY, led by volume growth of ~11%. Consolidated volumes grew by 6% YoY. Home care segment grew by 14% YoY, Personal care was up 17% YoY. International business grew by 5.4% YoY, with GUAM growing by 6.5% YoY. Indonesia returned to positive territory, growing by 8.2% YoY.
  • Gross margin expanded by ~340 bps YoY to 52.9%.
  • Employee cost grew by 10% YoY, while as % of sales, it stood at 9.4%. Advertising spend increased by 21% YoY and as % of sales it stood at 7% (versus 6.3% in 4QFY22). Other expenses increased by 4% YoY.
  • Despite advertising spends inching up, EBITDA grew by 32% YoY to Rs 6.6 bn. EBITDA margin came to 20.8%, expanding by ~350 bps YoY. Adjusted PAT grew by 24% YoY to Rs 4.7 bn.

Consolidated Q4 - Performance Highlights

Subsegment Performance

4Q FY 2023 consolidated sales grew by 10% in INR led by volume growth of 6%; constant currency growth of 14% year-on-year

  • India business sales grew by 12% year-on-year led by volume growth of 11%
  • Indonesia sales grew by 8% in INR and 5% in constant currency terms, year-on-year; ex-Hygiene growth of 14% and 11% in INR and constant currency respectively
  • Africa, USA and Middle East sales grew by 6% in INR and 8% in constant currency terms, yearon-year
  • Latin America & SAARC sales declined by 3% in INR and grew by 64% in constant currency terms, year-on-year.

India Business Performance

  • 4Q FY 2023 India sales grew by 12% to INR 1,789 crore; volume grew by 11%
  • 4Q FY 2023 EBITDA grew by 26% to INR 475 crore
  • 4Q FY 2023 Net Profit without exceptions and one-offs grew by 17% to INR 406 crore

Segmental Performance

Home care segment grew by 14% YoY, with a 2-year CAGR of 6%. Growth was driven by premium formats of electrics and aerosols, with both non-mosquito portfolio and mosquito portfolio (80% salience) growing in double digits.

Personal Wash & Hygiene segment continued its momentum with ~17% YoY sales growth (2-year CAGR of 19%). The company continued to gain market share and deepen penetration through micro-marketing initiatives and consistent marketing investments.

Indonesia Business Performance

Core business performance improves in Indonesia with sales growth of 5% in constant currency terms. Sales, excluding Hygiene (Saniter), saw a growth of 11% in constant currency terms. EBITDA margins at 21.5% were flat year-on-year. We also completed the transition to a distributor model.

Africa, USA and Middle East Business Update

Africa, USA and Middle East cluster delivered high single-digit sales growth of 8% in constant currency terms. Performance was impacted by election and demonetisation in Nigeria; however, business saw recovery in March 2023. We continue to deliver double-digit sales growth in the FMCG category. EBITDA margins at 10% expanded by 860 bps year-on-year due to a lower base.

Concall Highlights

  • India branded business grew 16% with volume growth of 13%. Home care grew 14% with 12% volume growth while personal care grew 17% with 15% volume growth. HI grew in teens with early double digit volume growth.
  • GAUM was impacted due to demonetization and election in Nigeria. Notably, March performance witnessed improvement. In FY23, direct distribution has increased by 1.8x and 2x in Nigeria and Kenya.
  • In FY23, sampling was done to 3mn households and would increase to 6mn in FY24
  • In Indonesia, simplification in sales and distribution is done and should help in business recovery.
  • India should witness price decline while in international business could witness price increase. On a consolidated basis growth would be led by volume and very less of pricing.

Historical Financial Performance

Profit and Loss

Balance Sheet

Cash Flow

Margin and Profitability


  • Economic slowdown
  • Global economic volatility
  • Higher commodity prices
  • Forex volatility

Valuation and Outlook

This quarter, GCPL's operational performance exceeded our projections. GCPL has pleasantly pleased on the margins front. It is highly commended that the domestic business saw volume growth of 11%. The volume growth is anticipated to continue steady at mid-single digits on an overall basis. Future margin improvement will be aided by raw material price stability, cost-cutting initiatives, and the proper size of overseas business. Due to this quarter's strong performance and the company's expanding expectations for its foreign business, we continue to HOLD. The stock is presently priced at 42x EPS for the FY25E.


I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Business relationship disclosure:

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Stocx Research Club). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure:

Disc - Not an recommendation. Source - Company presentation, press release, conference call and

Disclosure legality:

I am not a SEBI Registered individual/entity and the above research article is only for educational purpose and is never intended as trading/investment advice.


Updated : Sep, 2023

Private Equity Valuation

Private Equity Valuation

Author : Mayur Kachhawa

Updated : Sep, 2023

IPO Analysis: Yatra Online

IPO Analysis of Yatra Online

Author : Shalom Martin

Updated : Sep, 2023

Nifty EPS grew around 7% in Q1FY24 and may grow 8% i...

Subdued discretionary consumer spending amid higher cost of living, higher cost of borrowings, and lingering global macro-headwinds affecting earnings

Author : Ashish Ghosh

Updated : Sep, 2023

Nifty stumbled from a lifetime high dragged by HDFC ...

Also, the diplomatic rift with Canada, fading hopes of an early election by Dec’23, and ONOE (one nation, one election) affected the Indian market

Author : Ashish Ghosh

Updated : Sep, 2023

Strong order book position and government support sh...

Tangible net worth of Salasar Techno Engineering Limited saw an improvement to INR399.60 crore in FY23 from INR281.10 crore in FY22. Overall, gearing has improved to 0.68x in FY23 in comparison to 0.86x in FY22. It has adequate liquidity position and ...

Author : TheAsianInvestor

Updated : Sep, 2023

Hindustan Unilever Limited: Strong market presence a...

Financial risk profile of Hindustan Unilever Limited is strong and is being supported by healthy operating cash flow, nil gearing, largely unutilised bank lines and stable net worth. The company has high operating efficiency due to its strong distribut...

Author : TheAsianInvestor

Updated : Jun, 2023

Godrej Consumer Products Ltd. (GCPL)

Q4FY23 and FY23 Result Analysis

Author : Aditya Sharma

Updated : Feb, 2023


With over 50 brands spread across 15 different categories, the company offers a wide range of products, including fabric solutions, home & hygiene, life necessities, skincare, cosmetics, hair care, oral care, deodorants, tea, coffee, ice cream & frozen...

Author : Akshita

Updated : Jan, 2023

Godrej Consumer Products Limited

Godrej Consumer Products Limited: A Q3FY23 Business Updates

Author : Akshay Rajawat

Updated : Dec, 2022

Hindustan Unilever Limited

Hindustan Unilever Limited; A FMCG Giant

Author : Aditya Sharma

Updated : Sep, 2022

Acrysil: Business Analysis

Acrysil is a rising smallcap delivering quartz sinks across the world. A testament of its quality is reflected in the presence of IKEA as the company's client. The company is also trying to expand its portfolio with products like premium bathroom fitti...

Author : Rising Investor

Updated : Jun, 2022

Equity Research Report: Sakar Healthcare

Sakar Healthcare Ltd is engaged in manufacturing of pharmaceutical formulations in the form of liquid injectables, tablets/ capsules, oral liquid syrups, dry powder injectables and syrups. Presently, its domestic sales accounts for 31% of revenues and ...

Author : Akshita

Updated : Jun, 2022


Newgen Software Technologies is a global software Company and is engaged in the business of software product development including designing and delivering end-to-end software solutions covering the entire spectrum of software services from workflow au...

Author : Akshita

Updated : Jun, 2022

Nifty and Bank Nifty Tumbles Due to Weak Global Cues...

Nifty and Bank Nifty tumbles due to weak global cues lead by higher inflation data, higher crude oil prices and weakening currency.

Author : Shalom Martin

Updated : Jun, 2022

Equity Research Report: Shree Renuka Sugar

Shree Renuka Sugars is a global agribusiness and bio-energy corporation. The Company is one of the largest sugar producers in the world, the leading manufacturer of sugar in India, and one of the largest sugar refineries in the world.

Author : Akshita

Updated : Jul, 2022

Equity Research : Tata Consumer Products Limited

TCPL future ambitions remain aggressive, At 17% EPS CAGR over FY22-25e, TCPL should deliver industry-leading growth within indian FMCG.

Author : Shalom Martin

Updated : Jul, 2022

Equity Research: Birlasoft Ltd

Birlasoft, a small-cap IT company, has an upside potential of 35%. The company’s repeated demonstration of ‘walking the talk’ makes us believe that it is on track to achieve its stated target of USD1bn revenue by FY25E.

Author : Shalom Martin